Literature DB >> 17365823

Uterine sarcomas.

Farid Moinfar1, Masood Azodi, Fattaneh A Tavassoli.   

Abstract

A wide variety of sarcomas occur in the uterus but two subtypes - leiomyosarcoma and endometrial stromal sarcoma - account for a majority of those more routinely encountered. Using the 2003 World Health Organization classification, this review focuses on six uterine sarcomas: endometrial stromal sarcoma, undifferentiated endometrial sarcoma, leiomyosarcoma, rhabomyosarcoma, angiosarcoma and liposarcoma. The epidemiological, clinical, pathological and molecular features are presented along with therapeutic approaches. Familiarity with molecular aspects of these tumors and application of novel technologies in their assessment should be encouraged as they may provide alternate therapies resulting in improved survival for the patient. Clinical information necessary for accurate diagnosis of these lesions is emphasised. A multidisciplinary approach to management of patients with uterine sarcomas is essential for optimal management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17365823     DOI: 10.1080/00313020601136146

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  18 in total

Review 1.  A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature.

Authors:  Fong W Liu; Valerie B Galvan-Turner; Krista S Pfaendler; Teresa C Longoria; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2015-01-09       Impact factor: 8.661

Review 2.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

Review 3.  Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia.

Authors:  Esther Oliva
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

4.  Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.

Authors:  Riitta Koivisto-Korander; Ralf Butzow; Anna-Maija Koivisto; Arto Leminen
Journal:  Tumour Biol       Date:  2010-12-16

5.  [Changes in the TNM classification of gynecological tumors].

Authors:  L-C Horn; M W Beckmann; A Beller; D Schmidt; U Ulrich; P Hantschmann; C Wittekind
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

6.  A role for versican in the development of leiomyosarcoma.

Authors:  Paul A Keire; Steven L Bressler; Joan M Lemire; Badreddin Edris; Brian P Rubin; Maziar Rahmani; Bruce M McManus; Matt van de Rijn; Thomas N Wight
Journal:  J Biol Chem       Date:  2014-10-15       Impact factor: 5.157

Review 7.  Uterine Adenosarcoma: a Review.

Authors:  Michael J Nathenson; Vinod Ravi; Nicole Fleming; Wei-Lien Wang; Anthony Conley
Journal:  Curr Oncol Rep       Date:  2016-11       Impact factor: 5.075

8.  Molecular profiling of endometrial malignancies.

Authors:  Norasate Samarnthai; Kevin Hall; I-Tien Yeh
Journal:  Obstet Gynecol Int       Date:  2010-03-28

Review 9.  Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors.

Authors:  Rocco Bilancia; Marco Nardini; David Waller
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

10.  Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice.

Authors:  Pradeep S Tanwar; Ho-Joon Lee; LiHua Zhang; Lawrence R Zukerberg; Makoto M Taketo; Bo R Rueda; Jose M Teixeira
Journal:  Biol Reprod       Date:  2009-04-29       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.